Log in
Enquire now
‌

US Patent 9556167 TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)

Patent 9556167 was granted and assigned to Yale University on January, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Yale University
Yale University
Date Filed
May 1, 2013
Date of Patent
January 31, 2017
Patent Applicant
Yale University
Yale University
Patent Application Number
14397995
Patent Citations Received
‌
US Patent 11931430 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
0
‌
US Patent 12083181 Bi-functional molecules to degrade circulating proteins
0
‌
US Patent 11951190 Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer
0
Patent Inventor Names
David Spiegel
0
Kelly Fitzgerald
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9556167
Patent Primary Examiner
‌
Rei Tsang Shiao

Find more entities like US Patent 9556167 TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.